Hazelnut (Cor a 9) IgE Test · Blood

If you or your child has reacted to hazelnut, or shown up positive on a standard hazelnut allergy test, the next question is the one that actually matters: is this a real, potentially serious allergy, or a mild cross-reaction that does not pose much risk? This blood test helps answer that by measuring antibodies aimed at one specific hazelnut protein that is closely tied to true, systemic reactions.

Standard hazelnut tests pick up sensitization broadly, which means many people who test positive can actually eat hazelnut without trouble. Cor a 9 (which stands for Corylus avellana allergen 9, a storage protein inside the hazelnut seed) is different. Positivity here tends to track with the kind of allergy that causes whole-body reactions, not just an itchy mouth.

What This Test Actually Measures

The test measures IgE (immunoglobulin E, a class of antibody your immune system makes when it learns to attack something specific) in your blood that targets the Cor a 9 protein. Cor a 9 is an 11S legumin-like seed storage protein, meaning it is part of the nut's own food supply for the growing seedling. It is heat-stable and survives digestion, which is part of why reactions to it can be systemic rather than limited to the mouth.

A positive result means your immune system has learned to recognize this stable hazelnut protein. The higher the level, the more likely that recognition translates into a real-world reaction when you eat hazelnut.

Why True Hazelnut Allergy Matters

Hazelnut sensitization is common, but only a fraction of sensitized people actually react when they eat the nut. The hazelnut proteins your immune system targets predict very different outcomes. Cor a 1, a pollen-related protein, usually causes mild oral symptoms tied to birch pollen allergy. Cor a 9, a storage protein, is repeatedly linked in pediatric studies to systemic, potentially severe, anaphylactic reactions.

In several pediatric cohorts and meta-analyses, sensitization to Cor a 9 and a related storage protein (Cor a 14) has been associated with systemic reactions, while sensitization to Cor a 1 alone tends to relate to mild oral symptoms. This distinction is the whole point of ordering the test.

Diagnostic Accuracy in Children

In children, this is the population where Cor a 9 has been studied most rigorously. A meta-analysis of childhood hazelnut allergy reported that at a common low cutoff, Cor a 9 IgE caught roughly 78 out of 100 truly allergic children (sensitivity around 77.6 percent) and correctly cleared about 67 out of 100 tolerant children (specificity around 67.3 percent). The overall discriminating ability was strong, with an area under the curve of about 0.81.

What this means for you: a low or undetectable Cor a 9 result in a sensitized child shifts the odds toward tolerance, while a higher level shifts them sharply toward a real, clinically meaningful allergy. Combining Cor a 9 with Cor a 14 increases the post-test probability further, and pairs of positive storage-protein results carry combined specificity as high as 98 percent for clinical allergy.

Predicting Severity and Food Challenge Outcomes

Several pediatric studies have shown that higher Cor a 9 levels are significantly associated with failing an oral food challenge, the gold standard test where the patient eats measured doses of hazelnut under medical supervision. Lower levels are associated with tolerance and the ability to pass the challenge safely.

In a Japanese pediatric cohort, the combination of high Cor a 9 and low Cor a 1 was particularly useful for identifying true hazelnut allergy, with Cor a 9 alone achieving discriminating ability of 0.71. In a Spanish pediatric cohort from a region rich in lipid transfer protein allergens, storage proteins including Cor a 9 were the dominant drivers of severe reactions during food challenges.

Worth knowing: some studies have not found Cor a 9 levels to correlate with the exact grade of reaction severity, only with the binary question of allergic versus tolerant. So while higher values raise the probability of a systemic reaction, they should not be read as a precise severity score.

What Cor a 9 Tells You in Adults

In adults living in birch-pollen-rich areas, sensitization patterns shift. Adults are more often sensitized to Cor a 1, the pollen-related protein, and less often to storage proteins. When adults are positive for Cor a 9, it is highly specific, meaning a positive result is meaningful, but the overall accuracy of this test alone is lower.

In a Dutch adult study, Cor a 9 specificity ranged from 77 to 95 percent depending on the cutoff used, but overall discriminating ability for true allergy was modest. The practical takeaway: a high Cor a 9 in an adult with a suggestive history strongly supports real allergy, but a negative or low result does not always rule out clinical reactivity, and a supervised food challenge may still be needed.

Sensitization in Infants and Atopic Dermatitis

Cor a 9 sensitization can appear very early in life. In one study of young infants with atopic dermatitis, Cor a 9 IgE was already detectable in some children, sometimes independently of birch pollen sensitization. The clinical significance in this group is still being worked out, but it flags a subgroup of young children who may be at risk for significant hazelnut reactions later, even before they have ever eaten the nut.

How This Compares With Other Hazelnut Tests

Sources: Nilsson 2020 meta-analysis; Caffarelli 2021 systematic review; Borres 2022 review; Riggioni 2023 meta-analysis.

What this means for you: extract-based tests and skin pricks tend to over-call hazelnut allergy. Cor a 9, especially paired with Cor a 14, is what separates true allergy from incidental sensitization. If you've been told you or your child is allergic to hazelnut based only on a skin prick or generic blood IgE, this test can change the picture entirely.

Tracking Your Trend Over Time

Specific IgE levels are not static. In longitudinal data on total IgE in asthma patients, levels fluctuated by more than 50 percent between two measurements in about 67 percent of patients over five years. While threshold-based categories remained relatively stable, percentage shifts were common.

Within a single laboratory and method, specific IgE assays show good precision, typically under 15 percent coefficient of variation. Between different commercial platforms, however, results can disagree by more than 20 percent in roughly 80 percent of measurements. For meaningful serial tracking, use the same laboratory and assay each time, and look for clear, consistent trends rather than reacting to small movements.

A reasonable cadence: get a baseline, then retest annually if avoiding hazelnut, or earlier (within 3 to 6 months) if you are entering or completing oral immunotherapy or have had a clinical event that changes the management plan.

When Results Can Be Misleading

• Platform differences: switching between assay manufacturers can shift the reported number by more than 20 percent without any real biological change. Always compare like with like.
• Background atopy and obesity: total and specific IgE levels run higher in people with higher BMI (body mass index) and in those with multiple allergic conditions. This does not mean Cor a 9 is falsely positive, but it sets the context.
• Age-related sensitization shifts: in children under 3 with hazelnut sensitization, storage-protein patterns (Cor a 9 and Cor a 14) dominate. In adults living in birch-endemic regions, Cor a 1 sensitization is more common, so a low Cor a 9 in an adult does not always rule out clinical hazelnut reactions tied to other proteins.

What to Do With an Out-of-Pattern Result

A positive Cor a 9 result is not a license to ignore the rest of the picture, and a negative result is not always a green light. The decision pathway depends on the combination of findings.

• Positive Cor a 9 plus a clinical history of reaction: this strongly supports true hazelnut allergy. Strict avoidance and a personalized emergency plan, including injectable epinephrine, are the standard approach. Confirm with a board-certified allergist before liberalizing.
• Positive Cor a 9 with no reaction history: especially in young children with atopic dermatitis, this raises the question of whether to introduce hazelnut. This is a scenario for specialist input, not self-directed trial.
• Negative Cor a 9 with positive extract IgE or skin prick: this pattern often points to pollen-related cross-reactivity rather than true systemic allergy. Pair with Cor a 1 testing to clarify, and ask an allergist whether a supervised oral food challenge can be considered.
• Borderline or unclear results: order Cor a 14 alongside if not already done, and consider component-resolved testing for related tree nuts (walnut, cashew) where cross-reactivity may matter.

For any meaningful result, especially in children or anyone considering food challenge or immunotherapy, involve a board-certified allergist. The numbers guide the decision; they do not replace it.